600873 梅花生物
按盤價 
10.900 +0.680 (+6.654%) | 2024/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 12,642,718 | -6.96% | 27,760,612 | 27,937,153 | 23,060,956 | 17,049,514 | |
| 減：營業總成本 | 11,156,818 | -6.57% | 24,158,623 | 22,990,081 | 20,420,447 | 15,908,470 | |
| 其中:營業成本 | 10,177,206 | -8.18% | 22,297,122 | 20,915,784 | 18,585,713 | 14,548,203 | |
| 財務費用 | (75,237) | 786.15% | (33,427) | 83,877 | 176,935 | 140,944 | |
| 資產減值損失 | (1,988) | 41.03% | (5,415) | (5,958) | (20,500) | (12,310) | |
| 公允價值變動收益 | 1,960 | -106.73% | (38,116) | 32,687 | (22,024) | (82,213) | |
| 投資收益 | 14,671 | 479.34% | 7,627 | 24,365 | 307,906 | 35,723 | |
| 其中：對聯營企業和合營企業的投資收益 | (2,221) | -251.48% | 1,846 | 3,074 | (354) | 5,633 | |
| 營業利潤 | 1,682,738 | 1.55% | 3,813,393 | 5,160,179 | 2,929,432 | 1,186,031 | |
| 利潤總額 | 1,717,291 | 6.43% | 3,723,136 | 5,152,795 | 2,883,412 | 1,178,298 | |
| 減：所得稅費用 | 243,467 | 0.34% | 542,186 | 746,553 | 456,108 | 172,865 | |
| 淨利潤 | 1,473,824 | 7.51% | 3,180,950 | 4,406,242 | 2,427,304 | 1,005,432 | |
| 減：非控股權益 | -- | -- | -- | -- | 25,056 | 23,369 | |
| 股東淨利潤 | 1,473,824 | 7.51% | 3,180,950 | 4,406,242 | 2,402,248 | 982,064 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.500 | 11.11% | 1.060 | 1.440 | 0.780 | 0.320 | |
| 每股派息 (元) * | 0.175 | -- | 0.420 | 0.400 | 0.400 | 0.300 | |
| 每股淨資產 (元) * | 4.952 | 2.25% | 4.812 | 4.442 | 3.428 | 2.931 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
